You're right - not now. Just prescribing it first-line - even if the patient demands it - would almost certainly be considered malpractice (unless the patient experienced a really positive result). But there will be enough data in the reviewed literature - eventually - to justify off-label use.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.